Shamim Ruff Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Shamim Ruff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shamim Ruff. Shamim Ruff is SVP, Chief Regulatory Affairs in Sarepta Therapeutics, Inc. ($SRPT) and SVP, Regulatory Affairs & Qual in Sarepta Therapeutics, Inc. ($SRPT) and Director in REATA PHARMACEUTICALS INC ($RETA).
Latest Insider Trading Transactions of Shamim Ruff
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 146.01 | 780 | 113,888 | 780 | |
| Jun 14 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 146.01 | 5,000 | 730,050 | 5,000 | |
| Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 92.20 | 319 | 29,412 | 319 | |
| Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 92.20 | 10,000 | 922,000 | 10,000 | |
| Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 92.20 | 1,250 | 115,250 | 1,250 | |
| May 24 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Option Exercise | M | 0.00 | 4,432 | 0 | 0 | |
| May 24 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Payment of Exercise | F | 89.22 | 1,305 | 116,432 | 31,936 | 33.2 K to 31.9 K (-3.93 %) |
| May 24 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Buy | M | 0.00 | 4,432 | 0 | 33,241 | 28.8 K to 33.2 K (+15.38 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Option Exercise | M | 26.24 | 2,031 | 53,293 | 10,066 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Option Exercise | M | 13.90 | 469 | 6,519 | 6,134 | |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Payment of Exercise | F | 81.22 | 656 | 53,280 | 28,809 | 29.5 K to 28.8 K (-2.23 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Buy | M | 26.24 | 2,031 | 53,293 | 29,465 | 27.4 K to 29.5 K (+7.40 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Payment of Exercise | F | 81.22 | 80 | 6,498 | 27,434 | 27.5 K to 27.4 K (-0.29 %) |
| Mar 16 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Buy | M | 13.90 | 469 | 6,519 | 27,514 | 27 K to 27.5 K (+1.73 %) |
| Mar 07 2018 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Chief Regulato ... | Option Exercise | A | 71.45 | 70,000 | 5,001,500 | 70,000 | |
| Nov 08 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 14.76 | 10,000 | 147,600 | 31,144 | |
| Nov 08 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Sell | S | 55.00 | 10,000 | 550,000 | 27,045 | 37 K to 27 K (-26.99 %) |
| Nov 08 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 14.76 | 10,000 | 147,600 | 37,045 | 27 K to 37 K (+36.98 %) |
| Oct 05 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 14.76 | 11,500 | 169,740 | 41,144 | |
| Oct 05 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Sell | S | 50.00 | 11,500 | 575,000 | 27,045 | 38.5 K to 27 K (-29.84 %) |
| Oct 05 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 14.76 | 11,500 | 169,740 | 38,545 | 27 K to 38.5 K (+42.52 %) |
| Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 0.00 | 8,865 | 0 | 0 | |
| Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Payment of Exercise | F | 37.88 | 2,882 | 109,170 | 27,045 | 29.9 K to 27 K (-9.63 %) |
| Aug 07 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 0.00 | 8,865 | 0 | 29,927 | 21.1 K to 29.9 K (+42.09 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 14.76 | 1,500 | 22,140 | 52,644 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 13.90 | 4,388 | 60,993 | 5,098 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 13.71 | 6,250 | 85,688 | 17,708 | |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | S | 44.00 | 1,500 | 66,000 | 21,062 | 19.6 K to 21.1 K (+7.67 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 14.76 | 1,500 | 22,140 | 22,562 | 21.1 K to 22.6 K (+7.12 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Sell | S | 44.00 | 4,388 | 193,072 | 21,062 | 25.5 K to 21.1 K (-17.24 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 13.90 | 4,388 | 60,993 | 25,450 | 21.1 K to 25.5 K (+20.83 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Sell | S | 42.00 | 6,250 | 262,500 | 21,062 | 27.3 K to 21.1 K (-22.88 %) |
| Jul 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 13.71 | 6,250 | 85,688 | 27,312 | 21.1 K to 27.3 K (+29.67 %) |
| Mar 21 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Payment of Exercise | F | 30.30 | 177 | 5,363 | 21,062 | 21.2 K to 21.1 K (-0.83 %) |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | A | 32.63 | 4,189 | 136,687 | 4,189 | |
| Mar 14 2017 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | A | 32.63 | 20,811 | 679,063 | 20,811 | |
| Nov 10 2016 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 26.24 | 1,000 | 26,240 | 12,097 | |
| Nov 10 2016 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 26.24 | 1,000 | 26,240 | 21,239 | 20.2 K to 21.2 K (+4.94 %) |
| Sep 30 2016 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Option Exercise | M | 13.90 | 7,311 | 101,623 | 8,486 | |
| Sep 30 2016 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Sell | S | 60.00 | 7,311 | 438,660 | 20,239 | 27.6 K to 20.2 K (-26.54 %) |
| Sep 30 2016 | SRPT | Sarepta Therapeuti ... | Ruff Shamim | SVP, Regulatory Aff ... | Buy | M | 13.90 | 7,311 | 101,623 | 27,550 | 20.2 K to 27.6 K (+36.12 %) |
Page: 1